Polymerization of monomeric amyloid-β peptides (Aβ) into soluble oligomers and insoluble fibrils is one of the major pathways triggering the pathogenesis of Alzheimer's disease (AD). Using small molecules to prevent the polymerization of Aβ peptides can, therefore, be an effective therapeutic strategy for AD. In this study, we investigated the effects of mono-and bi-flavonoids on Aβ42 toxicity and fibrillogenesis and found that the bi-flavonoid, taiwaniaflavone (TF) effectively and specifically inhibits Aβ toxicity and fibrillogenesis. Compared to TF, the mono-flavonoid apigenin (AP) is less effective and less specific. Our data showed that differential effects of the mono-and bi-flavonoids on Aβ fibrillogenesis correlate with their varying cytoprotective efficacies. We also found that other bi-flavonoids, namely 2',8''-biapigenin, amentoflavone, and sumaflavone, can also effectively inhibit Aβ toxicity and fibrillogenesis, implying that the participation of two mono-flavonoids in a single bi-flavonoid molecule enhanced their activity. Bi-flavonoids, while strongly inhibited Aβ fibrillogenesis, accumulated nontoxic Aβ oligomeric structures, suggesting that these are offpathway-oligomers. Moreover, TF abrogated the toxicity of preformed Aβ oligomers and fibrils, indicating that TF and other bi-flavonoids may also reduce the toxicity of toxic Aβ species. Altogether, our data clearly show that bi-flavonoids, possibly due to the possession of two Aβ binders separated by an appropriate size linker, are likely to be promising therapeutics to suppress Aβ toxicity.
Introduction
Alzheimer's disease (AD) is a neurodegenerative disorder characterized by the progressive deposition of aggregated amyloid-β (Aβ) peptides in brain parenchyma and cerebral blood vessels [1] . Several isoforms of Aβ peptides are produced by the sequential proteolysis of the amyloid precursor protein (APP) by α-, β-and γ-secretases [1] . However, two major isoforms of Aβ are found in AD brains, Aβ40 and Aβ42. Native Aβ peptides spontaneously undergo conformational changes to form misfolded intermediates that are rich in β-sheets. These intermediates are typically unstable and undergo further aggregation to form higher-order oligomers, protofibrils and fibrils. Recent studies have shown that soluble Aβ oligomers and protofibrils formed during Aβ fibrillogenesis are the most toxic species and that their toxicity increases with the progression of AD [2] [3] [4] .
compared their efficacies to that of a monomeric flavonoid, AP. We demonstrate that the bi-flavonoids exert cytoprotective effect against Aβ toxicity more efficiently and specifically than AP by potently inhibiting the fibrillogenic process.
Materials and Methods

Materials
TF, 2',8''-biapigenin, amentoflavone, and sumaflavone were isolated as previously described [14] . AP, Thioflavin-T, staurosporine (STS), brefeldin A (BFA), etoposide (ETO) and dimethylsulphoxide (DMSO) were purchased from Sigma (St. Louis, MO). Phosphate buffered saline (PBS, 10 mM phosphate buffer, pH 7.4, 137 mM NaCl, and 2 mM KCl) was purchased from Amresco (Solon, Ohio). Dulbecco's modified eagle medium (DMEM), Ham's F12 and Fetal bovine serum (FBS) were purchased from Welgene (Daegu, Korea). Ac-DEVD-AMC (Caspase-3/7 substrate) was from A.G. Scientific Inc. (San Diego, CA). ECL plus western blotting detection kit was obtained from Amersham biosciences (Piscataway, NJ). Monoclonal antibody, 6E10, was acquired from Signet laboratories (Dedham, MA). All other chemicals were obtained from Sigma (St. Louis, MO) unless otherwise stated.
Preparation of Aβ42 Monomer, Oligomers, and Fibrils
Recombinant Aβ42 was prepared as described earlier [15] . Purified Aβ42 peptides were solubilized in 1,1,1,3,3,3-hexafluoro-2-propanol (HFIP), dried under a flow of nitrogen and further dried under vacuum for 30 min. Samples were stored at -20 o C until use. For toxicity and fibrillogenesis experiments, the peptide was dissolved in 0.1% NH 4 OH at a concentration of 2 mg/ ml followed by bath-sonication for 10 min. The peptide solution was then diluted to desired concentrations with PBS. Soluble Aβ42 oligomers were prepared as previously described with slight modifications [4] . Briefly, fresh Aβ42 was dissolved in serum-free DMEM (without phenol red), vortexed for 30 seconds and incubated at 4 o C for 24 h without agitation. Then, the sample was centrifuged for 15 min at 16,000 g and the supernatant, containing soluble Aβ40 oligomers, was removed. Fresh Aβ42 or Aβ42 oligomers were further diluted in serum-free DMEM prior to cellular treatment (without phenol red). To prepare Aβ42 fibrils, Aβ was incubated in PBS at 37 o C for 3 days and centrifuged at 16,000 g for 15 min.
Cell Culture and Toxicity Assay
Human neuroblastoma SH-SY5Y cells were cultured in Dulbecco's Modified Eagles Medium and Ham's F12 (1:1) supplemented with 10% (v/v) fetal bovine serum (FBS) and 1% antibiotics in 5% CO 2 at 37 o C. For cytotoxicity assay, cells were seeded at a density of 15,000 cells/well in 96-well plates. After incubation overnight, the medium was replaced with serum-free medium and the cells were further cultured for 12 h. Then, the cells were treated with 0.5 µM of Aβ42 or other cytotoxic chemicals (25 nM STS, 1 µM BFA or 1 µM ETO) in the absence or presence of flavonoids. The final DMSO concentration in cell culture was approximately 0.2% for all experiments. Cell viability was assessed by the MTT reduction assay. Briefly, 20 µL of MTT solution (5 mg/mL) was added to each well. After 2 h, 100 µL of solubilization buffer (20% (v/v) SDS solution in 50% (v/v) DMF, pH 4.7) was added. The absorbance was recorded at 570 nm after 12 to 16 h using a microplate reader (Spectra Max 190, Molecular Devices, Sunnywale, CA).
Caspase Activity Assay
The cells were then washed twice with ice-cold PBS before the addition of 40 µL of cell lysis buffer (pH 7.0, 20 mM HEPES-NaOH, 1 mM EDTA, 1 mM EGTA, 20 mM NaCl, 10 mM DTT, 1 mM phenylmethanesulpho- nylfluoride, 10 µg/mL leupeptin, 5 µg/mL pepstatin A, 2 µg/mL aprotinin, and 25 µg/mL ALLN). After incubating the sample on ice for 20 min, 60 µL (50 µL 2X) caspase assay buffer (20 mM HEPES-NaOH pH 7.0, 20 mM NaCl, 1.5 mM MgCl 2 , 1 mM EDTA, 1 mM EGTA and 10 mM DTT) was added. DEVDase (Caspase-3/7-like) activity was initiated by adding 10 µM Ac-DEVD-AMC at 30 o C and the release of AMC was monitored at excitation and emission wavelengths of 360 and 480 nm, respectively, using a microplate spectrofluorometer (Gemini-XS, Molecular Devices, USA). Caspase activity was calculated as the initial slope of the emission intensity vs. time curves.
Circular Dichroism (CD) Spectroscopy
CD spectra of Aβ42 in solution were recorded in a 1-mm path length cuvette at 0.5 nm interval and 1 nm resolution between 190 nm and 250 nm at 25 o C using a Jasco Spectropolarimeter (Jasco Co., Tokyo, Japan). Scan rate was 50 nm/min. Five scans were recorded and averaged for each sample. Aβ spectra were determined by subtracting that of buffer (PBS containing 0.2% DMSO and 0.004% NH 4 OH). The spectra of Aβ incubated with TF or AP were obtained by subtracting background spectra given by TF or AP in buffer [15] . The background subtracted and average spectra were smoothed using the means-movement algorithm using the Jasco spectra analysis program.
Transmission Electron Microscopy (TEM)
A 5 µL aliquot of sample was adsorbed on Formvarcoated 200-mesh nickel grid for 15 min and air-dried overnight. Subsequently, the grid was negatively stained with 2% uranyl acetate for 1 min and washed with distilled water. The samples were then analyzed by TEM (H-7600, Hitachi, Japan) at an accelerating voltage of 80 kV at 40,000-fold magnification [14] .
Detection of Aβ42 Oligomers by Immunoblotting Assay
To detect the oligomeric forms of Aβ42, the peptide was incubated in PBS at 37 o C in the absence or presence of flavonoids. Peptide species in the reaction mixtures were crosslinked before analyzed using sodium dodecylsulphate-polyacrylamide gel electrophoresis (SDS-PAGE) except for freshly dissolved Aβ42 (control) which was boiled for 5 min before SDS-PAGE.
Briefly, glutaraldehyde was added to the sample at a final concentration of 0.01 % (v/v) and the mixture was incubated for 5 minutes. The crosslinking reaction was then terminated by an equal volume of SDS buffer (50 mM Tris buffer, pH 6.8, 10% glycerol, 2% SDS, and 0.1% β-mercaptoethanol). Samples were then run on a SDS-PAGE gel (16% acrylamide) without boiling, and transferred to a polyvinylidene difluoride membrane (Bio-rad laboratories, Hercules, CA). After blocking with 5% milk in Tris-buffered saline containing 0.2% (v/v) Tween 20 at room temperature for 1 h, the membranes were probed with primary monoclonal antibody 6E10 and the anti-mouse horseradish peroxidase-conjugated secondary antibodies [14] . The blots were visualized using ECL plus reagent kit (Amersham Biosciences, Piscataway, NJ).
Results
TF Specifically and Potently Inhibited Aβ Toxicity
The chemical structures of TF and other bi-flavonoids are shown in Fig. 1 . Note that TF, isolated from Selaginella tamariscina, is composed of two AP's connected by a 3,5''' linkage. First, we compared the cytoprotective effects of TF and AP on Aβ42-induced toxicity in cultured SH-SY5Y cells using the MTT assay, which assesses cell viability by measuring mitochondrial reductase activity [17] . Only ~1 µM TF was necessary to reduce the cell viability by 50% (EC 50 ) (closed circles in Fig. 2A ), while more than 10-times more AP was required to obtain a similar level of cell death (open circles in Fig. 2A ).
We also examined the effect of TF or AP on cell death induced by other known cytotoxic agents such as STS (a protein kinase inhibitor), BFA (an inhibitor of protein transport from ER to Golgi), and ETO (a topoisomerase II inhibitor). TF was less effective than AP at protecting cells from STS-induced cell death (closed circles in Fig. 2B ). The observed EC 50 of AP on STSexposed cells was more than 5 µM and AP was not able to completely suppress toxicity at concentrations up to 40 µM (open circles in Fig. 2B ). Moreover, TF was barely effective at rescuing BFA-and ETO-treated cells (closed circles in Fig. 2C and D) . On the other hand, TF had a marginal effect on STS-induced caspase-3/7 activation (DEVDase) which is a hallmark of apoptosis, whereas AP effectively inhibited the activation (Fig.  2F ). Known as a protein kinase inhibitor, STS induces mitochondria-mediated apoptosis in which caspases play important roles in signal transduction [29] , implying that the suppressive effect of AP on the cell death may be due to an inhibitory effect on a step of caspase-activating pathway, although the exact mechanism remains to be elucidated. Note that the treatment of Aβ42 induced only a low level of caspase-3/7 activity and consequently, the effects of the flavonoids on the activity were difficult to detect (Fig. 2E ). Taken together, it is clear that TF was highly effective at rescuing cells from Aβ42-inducedtoxicity, whereas AP was only moderately effective. In contrast to TF, AP demonstrated a broad spectrum, non-specific cytoprotection against several toxic insults including Aβ.
Kinetic Studies on Aβ Fibrillogenesis/Fibril Destablization in the Presence of TF or AP
Many polyphenolic compounds are known to influence Aβ fibrillogenesis by inhibiting or accelerating Aβ polymerization [18] . We examined and compared the effect of TF or AP in the polymerization of Aβ42 by Thioflavin-T fluorescence assay. In these experiments, 20 µM of Aβ42 was used because it is above the reported critical micelle concentration of the peptide [19] and forms fibrils in a reasonable time frame such that its aggregation kinetics can be easily captured. Fig. 3A shows the fluorescence profiles of Aβ42 aggregation with increasing TF concentration. The profiles exhibit the characteristic sigmoidal shape, expected for a nucleation-dependent polymerization mechanism [19, 28] , where fluorescence plateaued after 6 h. The final fluorescence level, indicative of the amount of mature fibrils formed, decreased with increasing TF concentration (Fig. 3A) . The addition of AP also decreased Thioflavin-T fluorescence levels, but less effectively compared to TF (Fig. 3B ). Semi-logarithmic plots of Thioflavin-T fluorescence vs. time gave a linear relationship for the indicated time ( Fig. 3C and D) . From these plots, t 1/2 values were obtained (see materials and methods), which gives us information about the kinetics of the nucleation step during the early stage of fibrillogenesis [16] . It is expected that the t 1/2 value would increase if the flavonoids inhibited the nucleation process, the rate-determining step of the polymerization. For Aβ incubated with TF, t 1/2 values were 55±2, 62±1, 64±1 and 70±1 (average ± standard deviation) min, for 0, 0.5, 1 and 2 µM of TF, respectively. For Aβ incubated with AP, t 1/2 values were 58±2, 65±2 and 73±2 min for at 1.25, 2.5, and 5 µM of AP. The small changes of t 1/2 values with either TF or AP indicated that flavonoids marginally act on the nucleation step [16] . We also noticed that the disappearance of the linearity shown in Fig. 3C and D at the higher concentrations flavonoids or upon longer incubation times, implying the involvement of unaccounted processes and thus, rendering the logistic equation invalid.
Next, we compared the effect of TF or AP on Aβ fibril extension by measuring Thioflavin-T fluorescence of fresh Ab samples seeded with preformed fibrils (nuclei). As shown in Fig. 3E and F, the fluorescence increased without a lag phase to give hyperbolic curves and reached pleatued in about 2 h [19, 28] . The addition of TF or AP led to concentration-dependent decreases of the final amount of fibrils formed. Consistent with our previous observation, TF was more effective at retarding fibril elongation compared to AP (Fig. 3E and F) . To further elucidate the difference between TF and AP in fibril extension, the initial rates of Aβ fibril extension, the slopes of the linear portion of the fluorescence profiles, were extrapolated and compared. TF and AP both . These were re-drawn using data from (A) and (B). F(t), the fluorescence unit at time t, was normalized by subtracting background.
decreased the rate of Aβ fibril extension with TF being the more effective inhibitor (Fig. 3G ). TF and AP did not significantly impact fibril nucleation during the lag phase ( Fig. 3C and D) , but once the rapid Aβ elongation phase is initiated, AP inhibited Aβ fibrillogenesis less efficiently (Fig. 3G) , which resulted in a large difference in the final level of fibrils formed ( Fig. 3H and I ). Our data clearly demonstrated that the effects of the two flavonoids on the fibril formation may stem from the different effects they exert on Aβ fibril extension. The initial rates of fibril extension in the absence or presence of TF were linearly dependent to Aβ42 concentration (Fig. 4A) . The linear relationship indicates that fibril extension is a first-order reaction with respect to Aβ concentration. The net rate of fibril extension has contributions from both polymerization and depolymerization [20] . To further elucidate whether the observed reduced fibril growth rate by flavonoids is due to decreased polymerization or increased depolymerization, effect of the flavonoids on the disaggregation of preformed Aβ42 fibrils was examined. As shown in Fig. 4C and 4B, the fluorescence of preformed fibrils rapidly decreased with increasing flavonoid concentration, indicating that incubating fibrils with flavonoids caused the fibrils to disaggregate. Again, TF was more effective than AP disaggregating fibrils. The IC 50 values of TF, AP and other bi-flavonoids for Aβ42 polymerization, extension, and disaggregation are summarized in Table 1 . Approximately 10-times more AP than TF was needed to inhibit fibril formation or to induce fibril disaggregation to the same degrees (Table 1) . Taken together, our data clearly show that TF is more antifibrillogenic than AP.
TF Inhibits Aβ42 Structural Transformation
To further understand the inhibitory role of TF or AP in Aβ fibrillogenesis, we measured the secondary structures of Aβ42 in the absence or presence of TF or AP by CD spectroscopy. 20 µM Aβ42 was used in these experiments. Freshly prepared Aβ42 in PBS (pH 7.4) showed strong negative ellipticity at ~195 nm ( Fig. 5A  and B) , indicative of a largely unfolded, presumably IC 50 is defined as concentration of the compound required to reduce the polymerization, fibril extension rate of fresh Aβ42 or destabilization of preformed Aβ42 fibrils by 50%. The values were calculated by plotting fluorescence (%) in logarithmic scale versus concentrations of compounds described as before [25] . Means ± standard deviation are shown.
monomeric state with random-coil properties [31, 32] . Upon incubation at 37 o C, the peptide showed changes in the far-UV CD spectrum, and reached a maximum negative ellipticity at 217 nm after 12 h (Fig. 5A and  B) . These changes arise from the formation of β-sheet structures in the peptides [15] . The random coil to β-sheet transition was not observed in the presence of TF at 20 µM Aβ where the peptide remained as a random coils for incubation times up to 12 h (Fig. 5A) . TF thus effectively suppressed the formation of β-sheet structures of Aβ peptides. In contrast, AP was largely ineffective at inhibiting the formation of β-sheets (Fig. 5B) , which is consistent with its poor anti-fibrillogenic activity compared to TF.
TF Accumulated Oligomeric Aβ Structures
Our fibrillogenesis and structural data (Fig. 3, 4 , and 5) clearly showed that TF potently inhibits Aβ42 fibrillogenesis and the formation of β-sheet structures. In addition, TF is also effective at disaggregating preformed amyloid fibrils. These properties of TF may explain its cytoprotective effect of Aβ-induced cell cytotoxicity (Fig. 2) . However, because the cells were incubated with monomeric Aβ42 at a lower concentration, 0.5 µM, rather than the 20 µM used in fibrillogenesis experiments, we further examined the effect of the flavonoids on Aβ fibrillogenesis in the same conditions (0.5 µM and 12 h incubation) as those used in cell culture experiments. Additionally, the effect of the flavonoids on the formation of Aβ oligomeric structures also need to be characterized since the oligomers are more cytotoxic than the fibrils [21, 22] and Thioflavin-T could not detect the oligomeric species [23] . For this purpose, Aβ species formed in the incubated samples were imaged with TEM. Aβ incubated alone was predominantly composed of beaded structures 6-20 nm in width and ~200 nm in length (Fig. 6A) . The morphology and size of these structures are consistent with those of protofibrils previously reported [4, 30, 33] . Mature fibrils were not observed in this sample, implying that cellular toxicity ( Fig. 2A) was likely to be due to Aβ oligomers and protofibrils. In the Aβ samples containing TF, however, protofibrillar structures were not observed. Instead, small spherical and branched structures were observed. In the Aβ samples containing AP, both beaded protofibrillar structures and amorphous deposits were present (Fig. 6A) .
To confirm whether Aβ structures formed in the absence or presence of TF or AP were oligomers, immunoblotting assay was performed using Aβ-specific antibody 6E10. In this experiment, we used a chemical crosslinker to crosslink the Aβ species prior to SDS-PAGE analysis in order to avoid SDS-induced dissociation of oligomers. To validate the method before probing the effect of the flavonoids on the formation of Aβ oligomers, preformed oligomers prepared as described in Materials and methods were crosslinked and visualized by the immunoblotting assay (Fig. 6B) . Compared to the incubated sample that was not crosslinked (Fig.  6B, lanes 2 and 3) , significantly more Aâ oligomers spanning a wide size range was detected in the crosslinked sample (Fig. 6B, lane 4) . Additionally, crosslinking did not result in the formation of oligomers in freshly dissolved Aβ (data not shown). Thus immunoblotting assay using crosslinked samples is a reliable method for detecting oligomers.
Without added flavonoids, 0.5 µM Aβ incubated for 3 h (Fig. 6C, lane 2) showed a range of higher molec- ular weight oligomers and the amount of monomeric Aâ (band at the bottom of the gel) was not significantly different compared to those in a freshly prepared Aâ sample (Fig. 6C, lane 1) . However, after 12 h of incubation, the monomeric Aβ band completely disappeared (Fig.  6D, lane 2) , indicating that all of Aβ have aggregated into higher molecular weight species. When TF was added to the Aβ samples, increasing amounts of small Aâ oligomers (dimers, trimers, and tetramers) were detected with increasing TF concentration after 3 h of incubation (Fig. 6C, lanes 3-5) . Significant amounts of monomeric Aâ remained in all of these samples. When incubated for longer times (12 h), all samples accumulated more small Aβ oligomers ( (Fig. 6D, lanes 3-5) while still containing significant amounts of monomeric Aβ. With the addition of AP, larger oligomers (MW >30 kDa) were observed ( Fig. 6C and D, lanes 6-8) , but not small molecular weight Aβ oligomers. Taken together, our data show that TF, but not AP, favored the formation and accumulation of small Aβ oligomers. These results are consistent with our TEM results (Fig. 6A) .
TF is Cytoprotective Against Preformed Aβ42 Oligomers and Fibrils
Our results so far show that TF is cytoprotective to cells exposed to monomeric Aβ42. The monomers, however, can be transformed into non-toxic oligomers in the presence of TF during the incubation time (12 h) (Fig. 6) . It has been widely reported that soluble Aβ oligomers are the primary cytotoxic species [21, 22] . We therefore tested whether TF or AP can counteract the toxicity of preformed oligomers and fibrils on cultured cells. Compared to freshly prepared Aβ42, preformed Aβ oligomers induced ~16% more cell death after a 12 h incubation period ( Fig. 2A and 7A ). The addition of TF was effective at rescuing the cells from oligomerand fibril-induced toxicity where 10 µM of TF decreased cell toxicity induced by oligomers by ~ 40% and nearly ameliorated the toxicity induced by Aβ fibrils (Fig. 7) . In contrast, AP did not rescue cells exposed to Aβ oligomers or fibrils (Fig. 7B) . These data suggests that TF was effective at blocking the toxicity induced by Aβ oligomers and fibrils while AP was completely ineffective, implying that AP is not cytoprotective against the toxic Aβ oligomers and fibrils formed before its treatment. However, our earlier data indicated that AP did exert some rescuing effect towards toxicity induced by Aβ monomers (Fig. 2A) . This is possibly due to weak, but significant anti-fibrillogenic property of AP at the early stages of fibrillogenesis as shown in Fig. 3 and 4. 
Effects of Other Related Bi-flavonoids in Aβ Toxicity and Fibrillogenesis
To determine whether the inhibition of Aβ42 toxicity and fibrillogenesis is a unique property to TF or a general property of bi-flavonoids, we tested other related bi-flavonoids [25, 34] , including 2',8''-biapigenin, amentoflavone and sumaflavone (Fig. 1) . All bi-flavonoids tested increased the viability of the cells treated with 0.5 µM fresh Aβ42, albeit with slightly higher EC 50 (~2.5 µM) compared to that of TF (Fig. 8A) . These biflavonoids also suppressed Aâ fibrillogenesis at conditions similar to those in cell culture (Fig. 8B) or at 20 µM Aβ42 (Table 1) . IC 50 for Aβ polymerization, extension and decomposition of the fibrils varied slightly among the bi-flavonoids (Table 1) . TF was the most anti-fibrillogenic compared to other bi-flavonoids. However, all of the bi-flavonoids examined so far were more effective than AP, implicating the importance of the dimeric flavonoid structure for their anti-fibrillogenic and cytoprotective effects. TEM and immunoblotting assays also revealed that the bi-flavonoids, similar to TF, favored the formation and accumulated oligomer-like structures (Fig. 8C and D) . Our data suggest that the accumulation of non-toxic Aâ oligomers as one of the mechanism by which bi-flavonoids exert their cytoprotective effect.
Discussion
Our results show that the bi-flavonoid TF potently and specifically inhibits toxicity induced by monomeric, oligomeric, or fibrillar Aβ ( Fig. 2A and 8A ). In contrast, the rescuing effect of AP on Ab-induced toxicity was less potent and nonspecific, as AP reduced cytotoxicity induced by a number of compounds, including Aβ, STS, BFO, and ETO by a similar degree ( Fig. 2A) . Caspase-3 activation in STS-induced cell death was suppressed by AP, consistent with other reports [24] , but less efficiently by TF (Fig. 2B ). Taken together, it is apparent that TF either interacts directly with Aβ or disrupts the specific toxicity pathway induced by Aβ. In contrast, AP exerts a general cytoprotective effect that is non-specific to Aβ toxicity. TF appears to possess the three basic structural features that have been attributed to its antifibrillogenic and cytoprotective effects: high binding affinity to Aβ, two binding groups, and an optimal length between the two binding groups. TF is composed of two mono-flavonoids, AP-3' and 5'''-AP. AP has been shown to efficiently block Aâ fibrillogenesis (Fig. 3) , consistent with previous study showing that the IC 50 of mono-flavonoids such as myricetin, quercetin, and morin for the formation, extension and destabilization of fibrillar Aβ were found to be in the range of 0.1-1 µM [25] . TF and other bi-flavonoids may share a common mechanism for attenuating Aβ toxicity and fibrillogenesis, through the accumulation of non-toxic oligomeric forms of Aβ ( Fig. 6 and 8) . All bi-flavonoids tested were more effective than the mono-flavonoid AP ( Table 1 ), suggesting that the possession of two mono-flavonoids in bi-flavonoids is a critical structural feature for inhibiting Aβ fibrillogenesis. In addition to possessing two flavonoids, TF also meets the third criteria of an optimal linker size between the two flavonoids (see Fig. 1 ). For the case of curcumin, the optimal length of the linker has been found to be between 8-16 Å [8] . Furthermore, rigidity of the TF backbone may give it the additional advantage of being an efficient Aβ aggregation inhibitor [8] . AP contains two phenyl groups connected by a heterocyclic ring. While these structural features may satisfy the first and second criteria, the length of the linker between the two rings may be shorter than the optimal length. Thus, the mono-flavonoid AP might act as a single binder. TF appears to be more effective at inhibiting Aβ fibril extension than nucleation (Fig. 3C) . Characteristic Aβ secondary structures, namely β-sheets, were not found in the presence of TF (Fig. 5A) . Furthermore, the linear relationship between the initial rate of fibril extension and the concentrations of Aβ implies that polymerization and depolymerization occur simultaneously (Fig.  4A) . Our results suggest that TF fundamentally alters the aggregation pathway of Aβ, possibly by interacting with free Aβ and preventing it from misfolding into the β-sheet conformation found in fibrils. The stoichiometry of TF binding to Aβ, however, is unknown. The requirement of the two phenyl groups in curcumin for its ability to inhibit Aβ aggregation implies the existence of at least two binding sites on Aβ [8] . Insertion of long flexible linker (>16 Å) between them prevented from inhibiting the aggregation [8] , which probably exclude an interaction of curcumin with multiple Aβ's. The similar speculation may be applicable to bi-flavonoids.
As shown in Fig. 6 , the presence of TF suppressed the formation of mature Aβ fibrils, but led to the formation and accumulation of Aâ oligomer-like structures. These results are in agreement with TF's antifibrillogenic property. However, since oligomeric Ab species have been found to be more toxic than monomeric or fibrillar Ab species [21, 22] , the presence of TF might increase Aβ cytotoxicity if the accumulated Aβ oligomers are the same as the "on-pathway" or toxic Aβ oligomers. This is clearly not that case, because cell viability increased significantly in the presence of TF (Fig.  2A) . Thus, the oligomeric aggregates accumulated in the presence of TF are not only structurally different than on-pathway Aβ aggregates (Fig. 5 ), they are also functionally different than oligomers obtained by Aβ incubation without TF. Consistent with earlier studies [26] , TF appears to redirect Aβ fibril formation to form unstructured and nontoxic "off-pathway oligomers" [26] . Moreover, TF abrogated the toxicity of preformed Aβ oligomers and fibrils (Fig. 7) , probably by disaggregating the toxic aggregates.
Development of small molecule inhibitors to inhibit toxicity has emerged as an encouraging approach to treat AD. Hence, several flavonoids have been currently being examined for their therapeutic potentials against amyloid-mediated diseases. Compared to mono-flavonoids, dimeric bi-flavonoids may be promising therapeutics because its monomeric moieties are good Aβ binders and that these moieties are separated by an appropriate length linker that satisfies structural requirements for the inhibition of Aβ fibrillogenesis. In conclusion, our results show that bi-flavonoids more specifically inhibit Aβ42-induced cytotoxicity than mono-flavonoid by redirecting and/or reverting toxic Aâ aggregates to form off-pathway, nontoxic, and unstructured Aβ oligomers and intermediate. This comparative study of mono-and bi-flavonoids suggests that dimeric flavonoids may be useful in sAD therapy.
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